scholarly journals Longitudinal Tumor Size and Neutrophil‐to‐Lymphocyte Ratio Are Prognostic Biomarkers for Overall Survival in Patients With Advanced Non‐Small Cell Lung Cancer Treated With Durvalumab

2020 ◽  
Author(s):  
Sergey Gavrilov ◽  
Kirill Zhudenkov ◽  
Gabriel Helmlinger ◽  
James Dunyak ◽  
Kirill Peskov ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Overall Survival ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Tumor Size ◽  
Small Cell ◽  
Neutrophil To Lymphocyte Ratio ◽  
Prognostic Biomarkers ◽  
Small Cell Lung ◽  
Lymphocyte Ratio

Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer

Lung Cancer ◽  
2017 ◽  
Vol 106 ◽  
pp. 1-7 ◽  
Author(s):  
Stephen J. Bagley ◽  
Shawn Kothari ◽  
Charu Aggarwal ◽  
Joshua M. Bauml ◽  
Evan W. Alley ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Neutrophil To Lymphocyte Ratio ◽  
Small Cell Lung ◽  
Lymphocyte Ratio
Sign in / Sign up

Export Citation Format

Share Document